These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3005653)

  • 1. Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection.
    Sulitzeanu D; Szigeti R; Klein G; Hennessy K; Kieff E
    J Virol; 1986 Apr; 58(1):230-2. PubMed ID: 3005653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
    Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and rheumatoid arthritis.
    Bluestein HG; Hasler F
    Surv Immunol Res; 1984; 3(1):70-7. PubMed ID: 6326237
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
    Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
    Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
    Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP).
    Sulitzeanu D; Szigeti R; Hatzubai A; Dillner J; Hammarskjöld ML; Klein G; Klein E
    Immunol Lett; 1988 Aug; 18(4):301-6. PubMed ID: 2846438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus proteins.
    Dillner J; Kallin B
    Adv Cancer Res; 1988; 50():95-158. PubMed ID: 2837072
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 10. Manipulation of the immune response by Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus: consequences for tumor development.
    Ressing ME; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):379-80. PubMed ID: 18992819
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma.
    Levine PH; Lamelin JP; Stevens DA
    IARC Sci Publ (1971); 1978; (20):483-94. PubMed ID: 215530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA; Sondel PM
    Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus.
    Liebowitz D; Wang D; Kieff E
    J Virol; 1986 Apr; 58(1):233-7. PubMed ID: 3005654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGNA-specific LIF production of human lymphocyte subsets.
    Szigeti R; Masucci G; Ehlin-Henriksson B; Bendtzen K; Henle G; Henle W; Klein G; Klein E
    Cell Immunol; 1984 Jan; 83(1):136-41. PubMed ID: 6319032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.
    Bihl F; Narayan M; Chisholm JV; Henry LM; Suscovich TJ; Brown EE; Welzel TM; Kaufmann DE; Zaman TM; Dollard S; Martin JN; Wang F; Scadden DT; Kaye KM; Brander C
    J Virol; 2007 May; 81(9):4904-8. PubMed ID: 17329344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
    Elliott SL; Pye SJ; Schmidt C; Cross SM; Silins SL; Misko IS
    J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor.
    Szigeti R; Luka J; Klein G
    Cell Immunol; 1981 Mar; 58(2):269-76. PubMed ID: 6260386
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.